Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REGENDER: ADRCs for Diabetic Foot Ulcer
NCT02866565Phase 2Not yet recruiting
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Jun 2023
- Primary completion
- Sep 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous adipose-derived stem/stromal cells in diabetic foot ulcer (DFU), sponsored by Assistance Publique-Hôpitaux de Marseille. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
autologous adipose-derived stem/stromal cells
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT02866565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02866565.